15e Rotary Rally - Zaterdag 16 september

De Rotary Rally is een gezellige en sportieve puzzelrit waaraan deelgenomen kan worden met een 'gewone' auto in de Tourklasse of met een 'classic car' in de Vintageklasse. De Rally wordt zoals altijd georganiseerd door Rotaryclub Zwijndrecht Waal en Devel en wordt wederom uitgezet door een team professionals. De... Lees meer

Op vrijdag middag 18 november kwamen de deelnemers aan de 225ste ENMC workshop uit alle delen van de wereld bijeen in Heemskerk (NH), om te discussiëren over de mogelijkheid van een Global Registry voor FSHD. Op zondagmorgen bereikten de deelnemers, waaronder George Padberg, Diana Kim en ondergetekende van het bestuur van de FSHD Stichting, de overeenstemming om een federale structuur te creëren voor een Global Registry, bestaande uit een 15-tal verplichte items. In zo'n opzet blijven de nationale registraties gewoon bestaan. Zo ook de Nederlandse registratie.

Ook werd besloten een Global FSHD consortium op te richten, dat leiding gaat geven aan de registratie, maar ook zaken als trialreadiness en biomarkers. De workshop werd mede gesponsord door de FSHD Stichting.

Consensus reached on a global FSHD registry. Global FSHD consortium created 
Lay Summary


If you are an individual with FSHD, or a family member, you may have been asked to join a patient registry. Perhaps you are wondering what a registry is?

Disease registries are an essential tool for advancing research to understand a disease, improve patient care, and develop treatments. Typically, registries collect patient contact information, and demographic and diagnosis data. In addition, registries may collect varying amounts of data about your health and symptoms. The data will be anonymized and accessible only by authorized individuals, to protect the privacy of patients and families who participate.

In the FSHD field, there are patient registries in at least 13 countries. On the one hand, that’s great news. On the other hand, having data on this rare disease scattered across so many registries that work in isolation is a cause for concern. Ideally, FSHD patient data from around the world should be collected in a single global registry or a federation of national registries that could talk to one another, so that we have data from as many patients as possible, gathered in a uniform way using the latest standards for diagnosing and describing the condition.

A group of registry curators worked with the FSHD Champions, an international alliance of FSHD patient advocacy organizations, to organize an international workshop to discuss how to move toward this vision of a global FSHD registry. We all agreed that the key goals for this registry are to:


  1. Accelerate research to understand and treat FSHD;
  2. Empower patients to gain insights from the data about their condition and improve their health and quality of life.

This second point is very important. Traditionally, registries have not given information back to patients. Doing so takes considerable thought and work, but we all feel strongly that providing this information to patients and families is an obligation we owe to the patient community.

Over the three-day workshop (November 18-20, 2016) supported by the European Neuromuscular Center (ENMC), 23 individuals from the U.S., Canada, U.K., France, Italy, Spain, the Netherlands, Czech Republic, Australia, New Zealand, representing academia, industry, and patient advocacy groups, gathered to review current FSHD registries.

 The participants of the 225th ENMC workshop on "A global FSHD Registry Framework"

We discussed issues in clinical and genetic diagnosis, and ideas for how to evolve from the current 13 registries toward a global network with a way to aggregate data from multiple registries. There was a powerful desire among the participants to collaborate and arrive at a consensus on a number of essential topics. We are happy to report that we delivered on our aims, and more.

The workshop attendees agreed on an updated list of “core data elements” (information that are considered fundamental for the description of disease in each subject) that all registries should collect, and drafted a set of questions that will enable patients to supply this data to registries. We plan to publish the new core data elements in the Neuromuscular Disorders journal and distribute them to all FSHD registry curators.

Very importantly, while FSHD patients show a very wide range of symptoms and severity, the new core data elements focus on a small subset of signs that are mostly likely present in an FSHD patient. This ensures that the registry will not exclude any FSHD patient, while limiting the number of questions that patients would need to answer about their clinical status.

We also agreed on a genetic definition of FSHD that reflects our latest knowledge of FSHD genetics. This allows for “non-penetrant” and “asymptomatic” individuals to be defined as carriers of FSHD based on their genetics, but who have no symptoms or have such mild symptoms that the individual does not notice them. This is important to isolate elements (genetic or environmental) that can interfere with the appearance of disease symptoms. It also excludes patients who appear to have FSHD but lack of what it is now considered the essential genetic basis for FSHD.

In addition, we agreed that FSHD registries should serve as a platform for research. By time-stamping patients’ updated information (rather than overwriting old information with new), a registry can track changes in patients’ health and symptoms over time. Researchers can send surveys to registry participants to gain insight into a wide range of topics, from pain management, the effects of exercise, diet, and medications, the impact of pregnancy and menopause, and so on. We agreed that such research surveys should be shared among the registries so that they can be used in different populations.

Buoyed by this success, we went even further. Dr. George Padberg proposed that an international consortium be formed to continue the work. Workshop organizers Rossella Tupler (Italy), Baziel van Engelen (The Netherlands), Hanns Lochmuller (UK), and June Kinoshita (USA, patient advocacy representative) were asked lead the new consortium, joined by Drs. Rabi Tawil (USA).

The new organization will be called the FSHD Consortium. The name leaves open the possibility of expanding beyond registries to drive international collaboration on a variety of future research studies and initiatives.

Establishment of the global registry and FSHD Consortium will enable us to achieve greater clarity on the nature of FSHD and on factors that can make a difference to patients’ health and quality of life.

Acknowledgements: We thank the European Neuromuscular Center for a generous grant to support the workshop. The FSH Society, FSHD Stichting, and Friends of FSH Research provided additional support.

List of FSHD Champions members:

FSHD Champions members Country
Amis FSHD France
Chris Carrino Foundation USA
Friends of FSH Research USA
FSH Society USA
FSHD Canada Foundation Canada
FSHD Europe EU
FSHD Global Research Foundation Australia
FSHD Stichting The Netherlands

 

FSHD Champions Allies Country
AFM Telethon France
Muscular Dystrophy Association USA
Muscular Dystorphy Campaign UK
MD Canada Canada
National Institutes of Health USA
Prinses Beatrix Spierfonds The Netherlands
Spieren voor Spieren The Netherlands

 

 June Kinoshita, FSH Society

  • Kahali

    FSHD gaat
    over mensen 

  • Sies

    FSHD is het 
    beste halen uit

    de dingen die
    je nog wel kan 

  • Vrielink

    FSHD is leven
    met pijn en
    vermoeidheid 

  • Bovens

    FSHD gaat
    over verlies

  • Gielesen

    FSHD gaat
    over je schuldig
    voelen 

  • Bilsen

    FSHD komt
    voor bij alle
    rassen en alle
    leeftijden

  • Weggemans

    Vandaag gaat
    FSHD over
    hoop op therapie

15e Rotary Rally - Zaterdag 16 september

De Rotary Rally is een gezellige en sportieve puzzelrit waaraan deelgenomen kan worden met een 'gewone' auto in de Tourklasse of met een 'classic car... Lees meer

CABARETIERS HALEN TON OP VOOR SPIERZIEKTE FSHD

Uitreiking bij voorstelling in Carre. Na maanden van voorbereiding was ‘Het Lachspierbal’ een feit: Op donderdagavond 14 september gaf Ronald Snijders samen met Mike Boddé, Dolf... Lees meer

ZONDER REGISTRATIE
GEEN MEDICIJN

Registreer u hier